Skip to main content
. 2024 May 29;84(5):443–458. doi: 10.1055/a-2286-6066

Fig. 8.

Fig. 8

 Study design of the CAPTOR BC trial and planned molecular analyses. ET = endocrine therapy, FFPE = formalin-fixed, paraffin-embedded tissues, HR = homologous recombination, OS = overall survival, PFS = progression-free survival, SNP = single-nucleotide polymorphism